Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summarize data on PZA resistance in clinical isolates from South Africa. PZA DST should be performed when considering its inclusion in treatment of patients with rifampicin-resistant TB or MDR-TB
Pyrazinamide (PZA) is an important first-line drug in all existing and new tuberculosis (TB) treatme...
Pyrazinamide (PZA) is an essential first-line tuberculosis drug for its unique mechanism of action a...
<div><p>Background</p><p>Besides inclusion in 1<sup>st</sup> line regimens against tuberculosis (TB)...
Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summariz...
BackgroundPyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its unique ability to...
BACKGROUND: The ongoing epidemic of multidrug-resistant tuberculosis (MDR-TB) in Georgia highlights ...
Background Pyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its unique ability t...
Pyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its unique ability to eradicate...
INTRODUCTION:Susceptibility testing for pyrazinamide (PZA), a cornerstone anti-TB drug is not common...
Includes bibliographical references (pages 47-56).Pyrazinamide (PZA) is an important first-line drug...
International audienceBackground: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) str...
Tuberculosis (TB) is a highly infectious disease that causes the second highest mortality rate in hu...
Besides inclusion in 1st line regimens against tuberculosis (TB), pyrazinamide (PZA) is used in 2nd ...
Abstract Background Tuberculosis (TB) is the leading cause of death from an infectious disease and t...
AbstractAims and objectivesThe aim of this study is to determine the prevalence of pyrazinamide (PZA...
Pyrazinamide (PZA) is an important first-line drug in all existing and new tuberculosis (TB) treatme...
Pyrazinamide (PZA) is an essential first-line tuberculosis drug for its unique mechanism of action a...
<div><p>Background</p><p>Besides inclusion in 1<sup>st</sup> line regimens against tuberculosis (TB)...
Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summariz...
BackgroundPyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its unique ability to...
BACKGROUND: The ongoing epidemic of multidrug-resistant tuberculosis (MDR-TB) in Georgia highlights ...
Background Pyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its unique ability t...
Pyrazinamide (PZA) is crucial for tuberculosis (TB) treatment, given its unique ability to eradicate...
INTRODUCTION:Susceptibility testing for pyrazinamide (PZA), a cornerstone anti-TB drug is not common...
Includes bibliographical references (pages 47-56).Pyrazinamide (PZA) is an important first-line drug...
International audienceBackground: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) str...
Tuberculosis (TB) is a highly infectious disease that causes the second highest mortality rate in hu...
Besides inclusion in 1st line regimens against tuberculosis (TB), pyrazinamide (PZA) is used in 2nd ...
Abstract Background Tuberculosis (TB) is the leading cause of death from an infectious disease and t...
AbstractAims and objectivesThe aim of this study is to determine the prevalence of pyrazinamide (PZA...
Pyrazinamide (PZA) is an important first-line drug in all existing and new tuberculosis (TB) treatme...
Pyrazinamide (PZA) is an essential first-line tuberculosis drug for its unique mechanism of action a...
<div><p>Background</p><p>Besides inclusion in 1<sup>st</sup> line regimens against tuberculosis (TB)...